MINNETONKA, Minn., Jan. 7, 2021 /PRNewswire/ -- Respicardia, Inc., the manufacturer of the only FDA-approved active implantable system for the treatment of central sleep apnea (CSA), announced today ...
A new device to treat central sleep apnea recently made its debut at UCHealth Medical Center of the Rockies in Loveland. In a recent breakthrough procedure, a man became the first patient in an ...
MINNETONKA, Minn., July 10, 2019 /PRNewswire/ -- Respicardia, Inc., the manufacturer of the only FDA-approved active implantable device for the treatment of central sleep apnea (CSA), today announced ...
MINNETONKA, Minn., Respicardia, Inc., a medical technology company developing innovative therapies that improve cardiovascular health, today announced that the Centers for Medicare and Medicaid ...
The FDA approved an implantable device, Respicardia’s Remede System, which helps fight moderate to severe cases of central sleep apnea, a condition where the brain doesn’t send proper signals to the ...
Athens, 19 May 2014: A novel device implanted under the skin like a pacemaker successfully treats central sleep apnoea (CSA) in heart failure patients, according to research presented today at the ...
‘Moderate to severe central sleep apnea and the health hazards that arise from it may have found a cure at last with a new implantable device, thus helping people with this condition to have a good ...
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL ® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that the United States Food and ...
Electric Shock -When operating under AC power, the rem ede System Programmer must be connected to a grounded power source to avoid risk of electric shock. Concomitant Active Implantable Devices -Use ...
RESULTS PRESENTED DURING LATE BREAKING SCIENTIFIC SESSION AT HFSA 2013 CSA is associated with increased mortality and hospitalization in heart failure (HF) patients. Studies show that CSA affects up ...
A novel device implanted under the skin like a pacemaker successfully treats central sleep apnoea (CSA) in heart failure patients, according to research presented today at the Heart Failure Congress ...
A novel device implanted under the skin like a pacemaker successfully treats central sleep apnea (CSA) in heart failure patients, according to research. The implantable system improves sleep and heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback